Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • aimeetal
    Junior Member
    • Mar 2012
    • 2

    #1

    Using Trinity with no replicates

    Hello,
    For financial reasons my lab could not use replicates for the 2 conditions of my RNA seq experiment... I am a grad student . I performed a differential expression analysis using Trinity with EdgeR (the built-in command).. I did get a subset of differentially expressed contigs. Does anyone know how Trinity/edgeR calls these particular contigs as differentially expressed when there are no replicates? The commands are all pre-set, so I'm not sure what is going on there.
  • chadn737
    Senior Member
    • Jan 2009
    • 392

    #2
    1) Do everything you can to convince your boss to spend money on replicates

    2) Look up the EdgeR package and read about it and what it does

    3) Open up the run_EdgeR.pl and try to understand what commands it is feeding EdgeR, it also helps if you post the exact arguments you used.

    4) I am not familiar with protocols by Trinity, but it looks like they may be feeding EdgeR RPKM normalized data rather than raw reads. I could be wrong, I did not look at the run_EdgeR.pl too closely. If this is the case, then this is an incorrect way of doing differential expression (not to mention the lack of replicates).

    Comment

    • aimeetal
      Junior Member
      • Mar 2012
      • 2

      #3
      haha @ #1.. yes very true. Thank you so much for the advice. I will do that.
      I'm wondering if it would almost make more sense to just extract the raw counts from the sam files and calculate the fold changes.. or run the raw counts through RSEM to normalize them somewhat and calculate the fold changes.. I would hate to think the Trinity pipeline uses incorrect commands when I am so trusting of what it is telling me to do

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...